262 related articles for article (PubMed ID: 26235729)
1. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
[TBL] [Abstract][Full Text] [Related]
2. Identifying and integrating patient and caregiver perspectives in clinical practice guidelines for percutaneous renal biopsy.
Gutman T; Lopez-Vargas P; Manera KE; Craig JC; Howell M; Tunnicliffe D; James LJ; MacGinley R; See E; Wong J; Voss D; Saunders J; Menahem S; Jesudason S; Tong A; Champion de Crespigny P
Nephrology (Carlton); 2019 Apr; 24(4):395-404. PubMed ID: 29797384
[TBL] [Abstract][Full Text] [Related]
3. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
[TBL] [Abstract][Full Text] [Related]
4. Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
Cho Y; Sautenet B; Gutman T; Rangan G; Craig JC; Ong AC; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort R; Perrone RD; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Johnson DW; Viecelli AK; Geneste C; Kim H; Kim Y; Oh YK; Teixeira-Pinto A; Logeman C; Howell M; Ju A; Manera KE; Tong A
Nephrology (Carlton); 2019 Dec; 24(12):1214-1224. PubMed ID: 30663163
[TBL] [Abstract][Full Text] [Related]
5. Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units.
Miller HM; Tong A; Tunnicliffe DJ; Campbell D; Pinter J; Commons RJ; Athan E; Craig JC; Gilroy N; Green J; Henderson B; Howell M; Stuart RL; van Eps C; Wong MG; de Zoysa J; Jardine MJ
Hemodial Int; 2017 Apr; 21(2):213-223. PubMed ID: 27389043
[TBL] [Abstract][Full Text] [Related]
6. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.
Simms RJ; Thong KM; Dworschak GC; Ong AC
Nephrol Dial Transplant; 2016 Jul; 31(7):1130-40. PubMed ID: 26268712
[TBL] [Abstract][Full Text] [Related]
7. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.
Rangan GK; Alexander SI; Campbell KL; Dexter MA; Lee VW; Lopez-Vargas P; Mai J; Mallett A; Patel C; Patel M; Tchan MC; Tong A; Tunnicliffe DJ; Vladica P; Savige J
Nephrology (Carlton); 2016 Aug; 21(8):705-16. PubMed ID: 26511892
[No Abstract] [Full Text] [Related]
8. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
Cho Y; Tong A; Craig JC; Mustafa RA; Chapman A; Perrone RD; Ahn C; Fowler K; Torres V; Gansevoort RT; Ong ACM; Coolican H; Tze-Wah Kao J; Harris T; Gutman T; Shen JI; Viecelli AK; Johnson DW; Au E; El-Damanawi R; Logeman C; Ju A; Manera KE; Chonchol M; Odland D; Baron D; Pei Y; Sautenet B; Rastogi A; Sharma A; Rangan G;
Am J Kidney Dis; 2021 Feb; 77(2):255-263. PubMed ID: 32771648
[TBL] [Abstract][Full Text] [Related]
9. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
[TBL] [Abstract][Full Text] [Related]
10. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Psychosocial Care.
Tong A; Mallett A; Lopez-Vargas P; Rangan GK
Semin Nephrol; 2015 Nov; 35(6):590-594.e5. PubMed ID: 26718163
[No Abstract] [Full Text] [Related]
11. Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
Perrone RD; Neville J; Chapman AB; Gitomer BY; Miskulin DC; Torres VE; Czerwiec FS; Dennis E; Kisler B; Kopko S; Krasa HB; LeRoy E; Castedo J; Schrier RW; Broadbent S
Am J Kidney Dis; 2015 Oct; 66(4):583-90. PubMed ID: 26088508
[TBL] [Abstract][Full Text] [Related]
12. 'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
Logeman C; Cho Y; Sautenet B; Rangan GK; Gutman T; Craig J; Ong A; Chapman A; Ahn C; Coolican H; Tze-Wah Kao J; Gansevoort RT; Perrone R; Harris T; Torres V; Fowler K; Pei Y; Kerr P; Ryan J; Johnson D; Viecelli A; Geneste C; Kim H; Kim Y; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Parasivam G; Tong A
BMJ Open; 2020 Oct; 10(10):e038005. PubMed ID: 33040007
[TBL] [Abstract][Full Text] [Related]
13. European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants.
; Harris T; Sandford R; ;
Nephrol Dial Transplant; 2018 Apr; 33(4):563-573. PubMed ID: 29309655
[TBL] [Abstract][Full Text] [Related]
14. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Diet and Lifestyle Management.
Campbell KL; Rangan GK; Lopez-Vargas P; Tong A
Semin Nephrol; 2015 Nov; 35(6):572-581.e17. PubMed ID: 26718161
[No Abstract] [Full Text] [Related]
15. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.
Neijenhuis MK; Kievit W; Perrone RD; Sloan JA; Erwin P; Murad MH; Gevers TJG; Hogan MC; Drenth JPH
BMC Nephrol; 2017 May; 18(1):169. PubMed ID: 28545401
[TBL] [Abstract][Full Text] [Related]
16. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
[TBL] [Abstract][Full Text] [Related]
17. Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership.
Harris T; Bridges HR; Brown WD; O'Brien NL; Daly AC; Jindal BK; Mundy GS; Ong A; Power AJ; Sandford RN; Sayer J; Simms RJ; Wilson PD; Winyard PJD; Tarpey M
BMJ Open; 2022 Jun; 12(6):e055780. PubMed ID: 35705349
[TBL] [Abstract][Full Text] [Related]
18. Spanish guidelines for the management of autosomal dominant polycystic kidney disease.
Ars E; Bernis C; Fraga G; Martínez V; Martins J; Ortiz A; Rodríguez-Pérez JC; Sans L; Torra R;
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv95-105. PubMed ID: 25165191
[TBL] [Abstract][Full Text] [Related]
19. Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
Kelson M; Akl EA; Bastian H; Cluzeau F; Curtis JR; Guyatt G; Montori VM; Oliver S; Schünemann HJ;
Proc Am Thorac Soc; 2012 Dec; 9(5):262-8. PubMed ID: 23256169
[TBL] [Abstract][Full Text] [Related]
20. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
